WHO ICTRP trial
The effect of methotexate and hydroxychloroquine on lichen planopilaris
IRCT2015062822959N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015062822959N1 |
|---|---|
| Public title | The effect of methotexate and hydroxychloroquine on lichen planopilaris |
| Scientific title | Clinical trial of comparison of methotrexate versus hydroxychloroquine on disease activity index in patients with lichen planopilaris |
| Primary sponsor | Vice Chancellor for Research, Isfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Lichen planopilaris. Follicular lichen planus;Follicular lichen planus |
| Interventions | Intervention 1: Methotrexate (15 mg/week orally, in one day) will be administered in one group (15 patients) and for 6 months. Intervention 2: Hydroxychloroquine sulfate (Two tablets daily that is equivalent to 400 mg) administered in the… |
| Registration date | Aug 19, 2015 |
| Target size | 24 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: